ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced the presentation of ...

Allergic diseases are a diverse group of conditions characterized by hypersensitivity reactions to otherwise harmless ...

A new preclinical study from Massachusetts General Hospital in the United States, has found that even short-term consumption ...

Homozygous but not heterozygous loss of Pten in sporadic mouse models of SHH-medulloblastoma greatly accelerates tumor formation, not metastasis, through increased survival of differentiated cells and ...

Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...

引言从正常的组织修复滑向失控的恶性肿瘤时，我们往往会陷入一种线性的思维定势：以为这是一场由基因突变不断累积而直接导致的细胞“叛变”。然而，真实的生命图景远比这复杂得多。4月15日，《Cell》的研究报道“Oncogenic and ...

As we age, our cells accumulate genetic changes—mutations—some of which open the door to cancer. Scientists call these ...

This important study advances a new computational approach to measure and visualize gene expression specificity across different tissues and cell types. The framework is potentially helpful for ...

The field of agricultural microbiology has become pivotal in addressing the challenges of crop productivity and soil health under extreme environmental ...

Researchers from The University of Texas MD Anderson Cancer Center will present breakthrough studies at the American Association for Cancer Research (AACR) Annual Meeting 2026.

Takara Bio USA, Inc. today announced the launch of its CSP Program and announced the certification of Admera Health on the ...